Daewoong Pharmaceutical acquires GMP approval from EU for Nabota Factory
Acquiring the cGMP from the U.S. last May and the GMP from the Health Canada, Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabota Factory acquired the EU GMP from the European Medicines Agency(EMA) on the 18th.
Daewoong Pharmaceutical turned in the marketing authorization application for Nabota ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
